HIV Diagnostics and Vaccines: It Takes Two to Tango
The Journal of Infectious Diseases · 2024
DOI: 10.1093/infdis/jiae113 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Will Colón und 19 weiteren Autor:innen. Beteiligte Einrichtung: Johnson & Johnson Global Public Health Research and Development, Beerse, Belgium. Hauptthemen laut MEDLINE: HIV Infections, AIDS Vaccines, HIV-1. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Janssen Pharmaceutica NV, Janssen Vaccines & Prevention B.V., NIH.
Abstract (Originalsprache)
Current serologic tests for HIV screening and confirmation of infection present challenges to the adoption of HIV vaccines. The detection of vaccine-induced HIV-1 antibodies in the absence of HIV-1 infection, referred to as vaccine-induced seropositivity/seroreactivity, confounds the interpretation of test results, causing misclassification of HIV-1 status with potential affiliated stigmatization. For HIV vaccines to be widely adopted with high community confidence and uptake, tests are needed that are agnostic to the vaccination status of tested individuals (ie, positive only for true HIV-1 infection). Successful development and deployment of such tests will require HIV vaccine developers to work in concert with diagnostic developers. Such tests will need to match today's high-performance standards (accuracy, cost-effectiveness, simplicity) for use in vaccinated and unvaccinated populations, especially in low- and middle-income countries with high HIV burden. Herein, we discuss the challenges and strategies for developing modified serologic HIV tests for concurrent deployment with HIV vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Johnson & Johnson Global Public Health Research and Development, Beerse, Belgium.
- Janssen Vaccines and Prevention B.V., Leiden, the Netherlands.
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington.
- LH Consulting, Berkeley, California.
- Kenya Medical Research Institute, Nairobi, Kenya.
- National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
ORCID-Profile: Valérie Oriol-Mathieu, Ferdinard Adungo
Förderung
- Janssen Pharmaceutica NV
- Janssen Vaccines & Prevention B.V.
- NIH
Zitieren
APA
Colón, W., Oriol-Mathieu, V., Hural, J., Hattingh, L., Adungo, F., Lagatie, O., Lavreys, L., Allen, M., Anzala, O., Espy, N., Fransen, K., Garcia, P. J., Maciel, M., Murtagh, M., Peel, S. A., Peeling, R. W., Tan, L. L. J., Warren, M., Pau, M. G., & D'Souza, P. M. (2024). HIV Diagnostics and Vaccines: It Takes Two to Tango. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae113
Vancouver
Colón W, Oriol-Mathieu V, Hural J, Hattingh L, Adungo F, Lagatie O, et al. HIV Diagnostics and Vaccines: It Takes Two to Tango. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiae113
BibTeX
@article{Coln2024,
author = {Colón, Will and Oriol-Mathieu, Valérie and Hural, John and Hattingh, Lucy and Adungo, Ferdinard and Lagatie, Ole and Lavreys, Ludo and Allen, Mary and Anzala, Omu and Espy, Nicole and Fransen, Katrien and Garcia, Patricia J and Maciel, Milton and Murtagh, Maurine and Peel, Sheila A and Peeling, Rosanna W and Tan, Litjen L J and Warren, Mitchell and Pau, Maria Grazia and D'Souza, Patricia M},
title = {HIV Diagnostics and Vaccines: It Takes Two to Tango},
journal = {The Journal of Infectious Diseases},
year = {2024},
doi = {10.1093/infdis/jiae113}
}
EUVIMED